Van ECK boosted its Medtronic stake as the company reported strong earnings, raised guidance, and raised its dividend.

Van ECK Associates Corp increased its stake in Medtronic PLC by 0.7% in the third quarter, holding 2.6 million shares worth about $248.3 million. The company reported strong Q4 earnings of $1.36 per share, beating estimates, and revenue of $9.02 billion, up 5.8% year-over-year. Medtronic raised its 2026 full-year earnings guidance to $5.62–$5.66 per share and declared a $0.71 quarterly dividend, payable April 17 to shareholders of record March 27. The stock, trading at $91.26 with a market cap of $117.17 billion, has a 3.1% dividend yield and a "Moderate Buy" analyst consensus with a $110.74 target. Winthrop Capital Management reduced its stake by 95.6%, leaving 343 shares.